Carter Gould analyst CANTOR FITZGERALD

Currently out of the existing stock ratings of Carter Gould, 220 are a BUY (55.14%), 150 are a HOLD (37.59%), 29 are a SELL (7.27%).

Carter Gould

Work Performance Price Targets & Ratings Chart

Analyst Carter Gould, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 73.44% that have a potential upside of 27.11% achieved within 278 days. Previously, Carter Gould worked at BARCLAYS.

Carter Gould’s has documented 794 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.

Most recent stock forecast was given on AMGN, Amgen at 04-Nov-2026.

Wall Street Analyst Carter Gould

Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.

Average potential price target upside

ABBV AbbVie ALLK Allakos AMGN Amgen APLT Applied Therapeutics BIIB Biogen BMY Bristol-Myers Squibb Company CYTK Cytokinetics GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany NBIX Neurocrine Biosciences PFE Pfizer REGN Regeneron Pharmaceuticals TVTX Travere Therapeutics XLRN Acceleron Pharma GOSS Gossamer Bio RETA Reata Pharmaceuticals ALEC Alector CELG Celgene MTEM Molecular Templates VOR Vor Biopharma ACLX Arcellx ESPR Esperion Therapeutics INCY yte VRTX Vertex Pharmaceuticals SKIL Skillsoft Corp. NUVL Nuvalent PCVX Vaxcyte ACIU AC Immune Ltd BTAI BioXcel Therapeutics MT ArcelorMittal SA ADR CE Celanese GERN Geron PAYC Paycom Soft

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2020

$338

$46.69 (16.03%)

$282

10 days ago
(02-Nov-2026)

20/21 (95.24%)

$43.11 (14.62%)

335

Buy Since 05-Feb-2020

$322

$30.69 (10.54%)

$288

10 days ago
(02-Nov-2026)

45/46 (97.83%)

$27.11 (9.19%)

407

Buy Since 08-Dec-2021

$340

$48.69 (16.71%)

$300

10 days ago
(02-Nov-2026)

10/13 (76.92%)

$45.11 (15.30%)

514

Buy Since 02-Nov-2026

$342

$50.69 (17.40%)

$206

10 days ago
(02-Nov-2026)

19/20 (95%)

$47.11 (15.98%)

376

Buy Since 25-Feb-2026

$330

$38.69 (13.28%)

$280

10 days ago
(02-Nov-2026)

7/8 (87.5%)

$35.11 (11.91%)

173

Show more analysts

Please expand the browser size to see the chart

Which stock is Carter Gould most bullish on?

Potential upside of $246 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Carter Gould most reserved on?

Potential downside of -$9.14 has been obtained for BMY (BRISTOL-MYERS SQUIBB COMPANY)

What Year was the first public recommendation made by Carter Gould?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?